News

Absci Corporation’s ABSI share price has surged by 5.86%, which has investors questioning if this is right time to sell.
Absci gained on animal testing phaseout news, but the change has limited near-term impact on its investment case. Read why ...
In this article, we are going to take a look at where Absci Corporation (NASDAQ:ABSI) stands against the other best biotech penny stocks to invest in now. Goldman Sachs has spotlighted an often ...
Absci Corporation stock has dropped since January, driven by weak earnings and broader biotech sector pressures. Despite weak financials, Absci's internal pipeline, including ABS-101 and ABS-201 ...
Absci Corp. ((ABSI)) has held its Q4 earnings call. Read on for the main highlights of the call. Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed ...
Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates ...
VANCOUVER, Wash. and NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report ...
Absci Corp. research and ratings by Barron's. View ABSI revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
KeyBanc raised the firm’s price target on Absci (ABSI) to $9 from $5 and keeps an Overweight rating on the shares. Into Q1 earnings, the firm believes the focus for the HCIT sector will be on ...
7 analysts have expressed a variety of opinions on Absci (NASDAQ:ABSI) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table encapsulates their ...
In a report released today, Scott Schoenhaus from KeyBanc maintained a Buy rating on AbSci (ABSI – Research Report), with a price target of ...
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech ...